Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Thought Leadership
Latest Report
EvaluateMedTech World Preview 2018, Outlook to 2024
Report Highlights Worldwide medtech sales forecast to reach $595 billion by 2024, with a CAGR of 5.6%, anchored by familiar players Neurology set to be the fastest-growing device area with a CAGR of 9.1% between 2017 and 2024; diagnostic imaging and orthopedics will be the slowest, with annual growth of just 3.7% between these years Medtronic…
Report library
EvaluatePharma ワールドプレビュー 2018、2024年への展望 日本語版
分析ハイライト 全世界の処方箋薬売上の年平均成長率は6. 4% (2018-2024年CAGR)で、2024年には1兆2,000億ドルに達すると予測 2024年の処方箋薬売上に占める研究開発費の割合は16.9% オンコロジー領域は年平均12% …
Vantage Pharma, Biotech & Medtech Half-Year Review 2018
Report Highlights Big biotech and big pharma stocks were largely shunned by investors over the first half of the year Demand for new biotech issues shows no sign of…
EvaluatePharma World Preview 2018, Outlook to 2024
Report Highlights Worldwide prescription drug sales accelerate to $1.2 trillion by 2024, as unmet need drives annual compound growth to over 6% R&D spend is…
EvaluatePharma Orphan Drug Report 2018
Report Highlights Worldwide orphan drug sales are forecasted to grow at a CAGR of 11% from 2018-2024 The mean price of the top 100 USA orphan drugs is expected to…
ASCO: Skirmishes Break Out In The Great Lung Cancer Battle
Report Highlights For prescribers, at least, it is becoming ever more important to stay up to date with the numerous subgroups into which first-line NSCLC is being…
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.